Related Targets |
Target |
Mechanism CD47 inhibitors [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2/3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism PHD2 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism PHD2 inhibitors |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date08 Nov 2023 |
Sponsor / Collaborator |
Start Date17 Mar 2021 |
Sponsor / Collaborator |
Start Date01 Mar 2021 |
Sponsor / Collaborator |